A method to optimize PEG-coating of red blood cells

Area of Science:

• Biomedical Engineering
• Materials Science
• Transfusion Medicine

Background:

• Alloimmunization to donor blood group antigens is a major challenge in transfusion medicine.
• Masking antigens on red blood cells (RBCs) with poly(ethylene glycol) (PEG) is a potential solution to incompatibility.
• Optimization data for RBC PEGylation techniques are limited.

Purpose of the Study:

• To determine optimal conditions for covalently attaching PEG to human RBC membranes.
• To evaluate the effectiveness of PEGylation in preventing antibody binding.
• To assess the impact of PEGylation on RBC morphology.

Main Methods:

• Human RBCs were coated with activated 5 kDa methoxy-PEG using cyanuric chloride.
• Reactions were performed under varying pH, temperature, and time.
• PEGylation effectiveness was measured by inhibition of anti-D antiserum binding using hemocytometry and flow cytometry.
• RBC morphology was analyzed via light and scanning electron microscopy.

Main Results:

• Optimal PEGylation conditions were identified as pH 8.7, 14°C, and 30 minutes.
• An optimal PEG concentration could not be determined; >25 mg/mL resulted in echinocyte formation.
• 15 mg/mL is the highest recommended concentration for 5 kDa linear PEG.
• PEGylation effectively inhibited anti-D binding.

Conclusions:

• Specific reaction conditions significantly influence the efficiency of RBC PEGylation.
• Optimized PEGylation can mask RBC antigens, reducing alloimmunization risk.
• Careful control of PEG concentration is crucial to maintain RBC integrity and function.